Omron’s Blood Pressure Monitor with EKG Available for Pre-Order from April 15th

Omron Healthcare has received FDA clearance for its Complete™, blood pressure monitor.

Image: Freepik

Omron Healthcare has received FDA clearance for its Complete™, blood pressure monitor with EKG capability, and the company said it will start taking pre-orders on April 15th in the U.S. via its website. Complete is the first blood pressure monitor with EKG capability in a single device.

Related Omron and physIQ Collaborate to Improve Cardiovascular Patient Care

The device is an upper arm blood pressure monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. EKG readings can be measured by touching electrodes conveniently located on the top face and both sides of the monitor for easy access and comfort. EKG is an essential measurement for those with atrial fibrillation, also known as arrythmia or Afib, a condition causing irregular heartbeat that can lead to heart health-related complications, including increased risk of stroke and heart failure.

“Millions of Americans are living with Afib and a stroke risk that is five times higher than average, and many others may not know they have this condition since it is difficult to diagnose. Recent studies predict that the number of individuals with Afib could reach epidemic levels as a result of the growing aging Baby Boomer population. Monitoring this condition and the risk it carries is part of our Going for Zero mission. That’s why Omron developed Complete as an accessible, easy-to-use, at-home solution to provide a more complete heart health picture and greater peace of mind,” said Ranndy Kellogg, president & CEO of Omron Healthcare, Inc.

Omron headquarters in Kyoto, Japan (Image: Wikimedia commons)

Omron developed Complete in partnership with AliveCor, the market leader in FDA-cleared personal EKG technology. The device utilizes AliveCor’s new algorithm designed for improved detection of the possibility of Afib along with trusted medical-grade blood pressure measurement from Omron, said a press release.

“Irregular heartbeat is unpredictable and can be difficult to detect without regular monitoring. The Omron Complete empowers anyone who suspects they might have arrythmia or has family history of the condition to monitor their status easily at home,” said Kellogg.

Related Large U.S. Study Suggests Apple Watch Can Detect Irregular Heartbeat

Complete recently won the iF Design Award 2019, presented by iF International Forum Design GmbH, one of the world’s most prestigious design awards.

Complete will be available for USD$199.99 pre-order only in the U.S., with retail availability expanding to Amazon beginning May 1, 2019.

Sam Draper
April 12, 2019

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Apple Beats Samsung and Fitbit As North American Wearables Shipments Grow 10% Amid Pandemic

The value of North America's wearable band market in Q2 2020 remained flat year-on-year at US$2...

realme Launches Watch S Pro Smartwatch and True Wireless Buds Air 2

During the launch event of realme 8 Pro smartphone, the Oppo subsidiary also announced the latest...

Orchestra BioMed’s BackBeat Cardiac Neuromodulation Therapy Gets CE Mark for Hypertension Treatment

Orchestra BioMed, a Pennsylvania-based biomedical innovation company received...

Korean ECG Patch Gets FDA Clearance

Wellysis received clearance from the FDA to market its wearable electrocardiography (ECG) patch.
Discover more